ALLMedicine™ Pheochromocytoma Center
Research & Reviews 1,794 results
https://doi.org/10.1007/s12328-022-01684-8
Clinical Journal of Gastroenterology; Natsui H, Kohisa J et. al.
Aug 12th, 2022 - Von Hippel-Lindau disease (VHL) is frequently associated with pancreatic neuroendocrine tumors (PNETs). Here, we report a case of tumor-to-tumor metastasis in a VHL patient in whom colon cancer metastasized to the interior of a PNET. A 65-year-old...
https://clinicaltrials.gov/ct2/show/NCT01660984
Aug 9th, 2022 - Background: Medullary Thyroid Carcinoma (MTC) is a calcitonin producing tumor arising from the parafollicular C cells of thyroid. In children and adults, MTC is usually seen in association with Multiple Endocrine Neoplasia (MEN) 2A and 2B, which a...
https://clinicaltrials.gov/ct2/show/NCT03157128
Aug 8th, 2022 - This is an open-label, multi-center Phase 1/2 study in participants with advanced solid tumors, including RET fusion-positive solid tumors, MTC, and other tumors with RET activation. The trial will be conducted in 2 parts: Phase 1 (dose escalation...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354339
World Journal of Surgical Oncology; Yang L, Zhang Y et. al.
Aug 6th, 2022 - Pheochromocytoma is a neuroendocrine tumor that can overproduce catecholamines. Heart failure and Takotsubo Syndrome (TTS) caused by excessive catecholamines are uncommon pheochromocytoma complications. A 27-year-old woman was referred to our cent...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355203
PloS One; Manosroi W, Tacharearnmuang N et. al.
Aug 6th, 2022 - Primary aldosteronism (PA) is the most common cause of secondary hypertension. The diagnosis of PA currently requires multiple complicated measures. The aims of this study were to identify easy-to-obtain clinical and biochemical predictors, and to...
Guidelines 4 results
https://doi.org/10.1097/MPA.0000000000001792
Pancreas Fishbein L, Del Rivero J et. al.
May 4th, 2021 - This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the medical management and surveillance of metastatic and unresectable pheochromocytoma and paraganglioma held on October 2 and 3, 2019. The p...
https://doi.org/10.1038/gim.2018.28
Genetics in Medicine : Official Journal of the American C... Stewart DR, Korf BR et. al.
Jul 15th, 2018 - This practice resource is designed primarily as an educational resource for medical geneticists and other clinicians to help them provide quality medical services. Adherence to this practice resource is completely voluntary and does not necessaril...
https://doi.org/10.1530/EJE-16-0467
European Journal of Endocrinology; Fassnacht M, Arlt W et. al.
Jul 9th, 2016 - : By definition, an adrenal incidentaloma is an asymptomatic adrenal mass detected on imaging not performed for suspected adrenal disease. In most cases, adrenal incidentalomas are nonfunctioning adrenocortical adenomas, but may also represent con...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419007
Pancreas Chen H, Sippel RS et. al.
Jul 29th, 2010 - Pheochromocytomas, intra-adrenal paraganglioma, and extra-adrenal sympathetic and parasympathetic paragangliomas are neuroendocrine tumors derived from adrenal chromaffin cells or similar cells in extra-adrenal sympathetic and parasympathetic para...
Drugs 60 results see all →
Clinicaltrials.gov 92 results
https://clinicaltrials.gov/ct2/show/NCT01660984
Aug 9th, 2022 - Background: Medullary Thyroid Carcinoma (MTC) is a calcitonin producing tumor arising from the parafollicular C cells of thyroid. In children and adults, MTC is usually seen in association with Multiple Endocrine Neoplasia (MEN) 2A and 2B, which a...
https://clinicaltrials.gov/ct2/show/NCT03157128
Aug 8th, 2022 - This is an open-label, multi-center Phase 1/2 study in participants with advanced solid tumors, including RET fusion-positive solid tumors, MTC, and other tumors with RET activation. The trial will be conducted in 2 parts: Phase 1 (dose escalation...
https://clinicaltrials.gov/ct2/show/NCT03027388
Aug 4th, 2022 - Background: Primary gliomas are an incurable disease in spite of aggressive multimodality therapy consisting of craniotomy, irradiation, and chemotherapy. Therapeutic options for patients with recurrent glioma are limited, and there is an unmet ne...
https://clinicaltrials.gov/ct2/show/NCT01371201
Aug 4th, 2022 - PRIMARY OBJECTIVE: To determine the efficacy of Sunitinib on the progression-free survival at 12 months in subjects with progressive malignant pheochromocytoma and paraganglioma treated with sunitinib at a starting dose of 37.5 mg daily (continuou...
https://clinicaltrials.gov/ct2/show/NCT00004847
Aug 3rd, 2022 - Pheochromocytomas (PHEOs) and paragangliomas (PGLs) are rare and clinically important chromaffin cell tumors that typically arise from the adrenal gland or from extra-adrenal paraganglia, respectively. The clinical features and consequences of PHE...
News 78 results
https://www.onclive.com/view/car-t-cell-therapy-may-represent-a-new-option-in-medullary-thyroid-cancer
May 5th, 2022 - Investigators at the Perelman School of Medicine at the University of Pennsylvania (Penn) have recently initiated a clinical trial evaluating a novel CAR T-cell therapy in an effort to fill an unmet need for systemic treatment for patients with ad...
https://www.mdedge.com/fedprac/article/249919/nephrology/pheochromocytoma-incidental-finding-asymptomatic-older-adult-renal
Maryam Bushra Ahmed, Zayan Ahmed Sami et. al.
Dec 15th, 2021 - Pheochromocytoma is a rare catecholamine-secreting tumor of chromaffin cells of the adrenal medulla or sympathetic ganglia, occurring in about 0. 2 to 0.
https://www.onclive.com/view/influx-of-therapies-in-nets-prompts-questions-over-combinations-and-sequencing
Nov 19th, 2021 - Tyrosine kinase inhibitors (TKIs), hypoxia-inducible factor 2α (HIF-2α) inhibitors, and peptide receptor radiotherapy are generating excitement in the field of neuroendocrine tumors (NETs), explained Diane Reidy-Lagunes, MD. However, until more de...
https://www.mdedge.com/internalmedicine/article/248875/geriatrics/case-older-patient-t2d-has-recurrent-flushing
Douglas S. Paauw, MD
Nov 18th, 2021 - A 64 year-old man with type 2 diabetes complains of recurrent flushing for the past 6 months. He has had no other symptoms.
https://www.mdedge.com/fedprac/article/248532/diabetes/long-qt-and-cardiac-arrest-after-symptomatic-improvement-pulmonary
MAJ James I. Gragg, DO, CPT James D. Jones, MD et. al.
Nov 10th, 2021 - Abnormalities in the T-wave morphology of an electrocardiogram (ECG) are classically attributed to ischemic cardiac disease. However, these changes can be seen in a variety of other etiologies, including noncardiac pathology, which should be consi.